Invivyd to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025
Invivyd (Nasdaq: IVVD) has announced its participation in the Oppenheimer 35th Annual Healthcare Life Sciences Conference. Marc Elia, Chairman of the Invivyd Board of Directors, will deliver a presentation on Wednesday, February 12th, 2025 at 1:20 PM ET.
The presentation will be accessible via live webcast through the investor section of Invivyd's website at investors.invivyd.com. The recording will remain available for approximately 90 days after the event.
Invivyd (Nasdaq: IVVD) ha annunciato la sua partecipazione alla 35ª Conferenza Annuale Oppenheimer sulle Scienze della Vita e Sanità. Marc Elia, Presidente del Consiglio di Amministrazione di Invivyd, presenterà il suo intervento il mercoledì 12 febbraio 2025 alle 1:20 PM ET.
La presentazione sarà accessibile tramite una diretta streaming nella sezione investitori del sito web di Invivyd all'indirizzo investors.invivyd.com. La registrazione rimarrà disponibile per circa 90 giorni dopo l'evento.
Invivyd (Nasdaq: IVVD) ha anunciado su participación en la 35ª Conferencia Anual Oppenheimer sobre Ciencias de la Salud. Marc Elia, Presidente de la Junta Directiva de Invivyd, realizará una presentación el miércoles 12 de febrero de 2025 a las 1:20 PM ET.
La presentación estará disponible a través de una transmisión en vivo en la sección de inversores del sitio web de Invivyd en investors.invivyd.com. La grabación estará disponible durante aproximadamente 90 días después del evento.
Invivyd (Nasdaq: IVVD)는 오펜하이머 제35회 연례 헬스케어 생명과학 컨퍼런스에 참여한다고 발표했습니다. Marc Elia 회장은 2025년 2월 12일 수요일 오후 1:20 ET에 발표를 진행할 예정입니다.
발표는 Invivyd 웹사이트의 투자자 섹션인 investors.invivyd.com에서 생중계로 접속할 수 있습니다. 녹화본은 이벤트 종료 후 약 90일간 사용할 수 있습니다.
Invivyd (Nasdaq: IVVD) a annoncé sa participation à la 35ème Conférence Annuelle Oppenheimer sur les Sciences de la Vie et la Santé. Marc Elia, Président du Conseil d'Administration d'Invivyd, fera une présentation le mercredi 12 février 2025 à 13h20 ET.
La présentation sera accessible via une diffusion en direct dans la section investisseurs du site web d'Invivyd à l'adresse investors.invivyd.com. L'enregistrement restera disponible pendant environ 90 jours après l'événement.
Invivyd (Nasdaq: IVVD) hat seine Teilnahme an der 35. jährlichen Oppenheimer-Konferenz für Gesundheits- und Lebenswissenschaften bekannt gegeben. Marc Elia, Vorsitzender des Vorstands von Invivyd, wird am Mittwoch, den 12. Februar 2025, um 1:20 PM ET eine Präsentation halten.
Die Präsentation wird über einen Live-Stream im Investorenbereich der Webseite von Invivyd unter investors.invivyd.com zugänglich sein. Die Aufzeichnung bleibt etwa 90 Tage nach dem Ereignis verfügbar.
- None.
- None.
WALTHAM, Mass., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that Marc Elia, Chairman of the Invivyd Board of Directors, will be presenting at the Oppenheimer 35th Annual Healthcare Life Sciences Conference.
The presentation is set to take place at 1:20 PM ET on Wednesday, February 12th. The live webcast link will be available in the investor section of the company's website at https://investors.invivyd.com and will be archived for approximately 90 days following the event.
About Invivyd
Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2. Invivyd deploys a proprietary integrated technology platform unique in the industry designed to assess, monitor, develop, and adapt to create best in class antibodies. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates. Visit https://invivyd.com/ to learn more.
Contacts:
Media Relations
(781) 208-1747
media@invivyd.com
Investor Relations
(781) 208-1747
investors@invivyd.com
FAQ
When is Invivyd (IVVD) presenting at the Oppenheimer Healthcare Conference 2025?
How can investors watch Invivyd's (IVVD) Oppenheimer Conference presentation?
How long will Invivyd's (IVVD) Oppenheimer Conference presentation be available for replay?
Who is representing Invivyd (IVVD) at the 2025 Oppenheimer Healthcare Conference?
